{"schema_version":"1","generated_at":"2026-11-11T19:55:00.089Z","data_as_of":null,"url":"https://www.findmykol.com/kol/skye-mayo","json_url":"https://www.findmykol.com/kol/skye-mayo/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"skye-mayo","name":"Skye Mayo","credential":"MD, MPH","specialty":"Surgical Oncology","specialty_raw":"Surgical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1134274830","orcid":"0000-0002-1631-9855","openalex":"A5011285023"},"summary":"Skye Mayo is an Oncology physician. OpenAlex indexes 154 publications with 3,996 citations (h-index 31); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":154,"cited_by_count":3996,"h_index":31,"latest_activity_year":2023,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT04251715","title":"mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"OHSU Knight Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT04251715","trial_url":"https://www.findmykol.com/trial/NCT04251715"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Intera Oncology, Inc","program_year":2023,"amount_usd":258.52,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1134274830"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1134274830","source":"payments"},"prescribing":{"data_year":2023,"areas_total":1,"areas_shown":1,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":100,"classes_total":2,"classes":[{"class":"Antidiarrheal microorganisms","setting":"prescribed","share_pct":55.6,"drugs":[{"name":"Creon","share_pct":100}],"max_beneficiaries":null},{"class":"Proton pump inhibitor","setting":"prescribed","share_pct":44.4,"drugs":[{"name":"Omeprazole","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2023,"office_pct":78.4,"facility_pct":21.6},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Updated Management of Colorectal Cancer Liver Metastases: Scientific Advances Driving Modern Therapeutic Innovations","year":2023,"journal":"Cellular and Molecular Gastroenterology and Hepatology","source_url":"https://doi.org/10.1016/j.jcmgh.2023.08.012","status":"verified"},{"title":"Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy: An International Survey of the HAI Consortium Research Network","year":2023,"journal":"Annals of Surgical Oncology","source_url":"https://doi.org/10.1245/s10434-023-14207-7","status":"verified"},{"title":"The multidisciplinary management of cholangiocarcinoma","year":2022,"journal":"Cancer","source_url":"https://doi.org/10.1002/cncr.34541","status":"verified"},{"title":"Socioeconomic and Geographic Disparities in the Referral and Treatment of Pancreatic Cancer at High-Volume Centers","year":2022,"journal":"JAMA Surgery","source_url":"https://doi.org/10.1001/jamasurg.2022.6709","status":"verified"},{"title":"Considerations and barriers to starting a new HAI pump program: an international survey of the HAI Consortium Research Network","year":2022,"journal":"HPB","source_url":"https://doi.org/10.1016/j.hpb.2022.08.008","status":"verified"}],"source":"works"},"contact":{"address_1":"1275 YORK AVE","address_2":"H-1206","city":"New York","state":"NY","zip":"100656007","phone":"212-639-7537","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1134274830","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2014-09-11","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}